DNA GTx

EGFR Mutation Test

Home > RT-PCR > EGFR Mutation Test

Targeted Mutation Testing for Precision Lung Cancer Care

Targeting EGFR for Precise Lung Cancer Treatment Decisions

DNA GTx’s EGFR Test is designed to detect 8 key mutations (55 known variants) within exons 18–21 of the EGFR gene, which are commonly associated with non-small cell lung cancer (NSCLC). This focused test delivers rapid and accurate results, enabling oncologists to identify patients eligible for EGFR-targeted therapies and make informed decisions for personalized lung cancer care.

Who is this Test for?

What it Screens for

Key Benefits

Turn Around Time

Do You Need a Doctor’s Request?

Yes. A doctor must order this test to ensure the results are properly interpreted and used to guide treatment.

How it Works?

Let’s Decode the Future of Health — Together

Get in touch today — let’s start a conversation that could change lives

*All information is handled with strict confidentiality.

Find Answers Today​

Early detection saves lives

*All information is handled with strict confidentiality.

Blogs